Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Journal of Biological Regulators and Homeostatic Agents
|
January 6, 2012
3,5-diiodo-L-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects
A Antonelli, P Fallahi, S M Ferrari, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 3, 2008
Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study
A Antonelli, P Fallahi, S M Ferrari, et al.
La Clinica Terapeutica
|
September 19, 2013
Mixed cryoglobulinemia and thyroid autoimmune disorders
P Fallahi, S M Ferrari, D Giuggioli, et al.
La Clinica Terapeutica
|
September 10, 2014
[Cryoglobulinemia and the α-chemokine IP-10]
A Corrado, V Mazzi, S M Ferrari, et al.
Clinical and Experimental Rheumatology
|
March 31, 2009
High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis
A Antonelli, P Fallahi, A Delle Sedie, et al.
Journal of Human Hypertension
|
March 14, 2008
High serum levels of CXC chemokine ligand 10 in untreated essential hypertension
A Antonelli, P Fallahi, M Rotondi, et al.
Oncology Reports
|
March 9, 2018
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells
P Fallahi, R Foddis, G Elia, et al.
Molecular Medicine Reports
|
June 15, 2018
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide
P Fallahi, R Foddis, G Elia, et al.
La Clinica Terapeutica
|
November 13, 2013
Hepatitis C virus infection and type 2 diabetes
P Fallahi, S M Ferrari, M Colaci, et al.
International Journal of Immunopathology and Pharmacology
|
June 16, 2012
High serum levels of CXC (CXCL10) and CC (CCL2) chemokines in untreated essential hypertension
A Antonelli, P Fallahi, S M Ferrari, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Journal of Biological Regulators and Homeostatic Agents
|
January 6, 2012
3,5-diiodo-L-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects
A Antonelli, P Fallahi, S M Ferrari, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 3, 2008
Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study
A Antonelli, P Fallahi, S M Ferrari, et al.
La Clinica Terapeutica
|
September 19, 2013
Mixed cryoglobulinemia and thyroid autoimmune disorders
P Fallahi, S M Ferrari, D Giuggioli, et al.
La Clinica Terapeutica
|
September 10, 2014
[Cryoglobulinemia and the α-chemokine IP-10]
A Corrado, V Mazzi, S M Ferrari, et al.
Clinical and Experimental Rheumatology
|
March 31, 2009
High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis
A Antonelli, P Fallahi, A Delle Sedie, et al.
Journal of Human Hypertension
|
March 14, 2008
High serum levels of CXC chemokine ligand 10 in untreated essential hypertension
A Antonelli, P Fallahi, M Rotondi, et al.
Oncology Reports
|
March 9, 2018
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells
P Fallahi, R Foddis, G Elia, et al.
Molecular Medicine Reports
|
June 15, 2018
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide
P Fallahi, R Foddis, G Elia, et al.
La Clinica Terapeutica
|
November 13, 2013
Hepatitis C virus infection and type 2 diabetes
P Fallahi, S M Ferrari, M Colaci, et al.
International Journal of Immunopathology and Pharmacology
|
June 16, 2012
High serum levels of CXC (CXCL10) and CC (CCL2) chemokines in untreated essential hypertension
A Antonelli, P Fallahi, S M Ferrari, et al.
Page
of 3